Whereas the pictilisib-mediated Hhip upregulation can be explained by epigenetic events (please see Results section), the different effects on Gli1 expression in the in vitro vs. the in vivo situation could be due to e.g. drug pharmacokinetics or the tumor microenvironment. The gene discussed is HHIP; the disease is neoplasm.